Wearable Gait Sensors
Wearable Sensors for Quantitation of Impaired Gait and Balance
1 other identifier
observational
600
1 country
1
Brief Summary
This research study is testing body-worn sensors to measure movement during simple tests of coordination, in order to evaluate the progression and severity of Spinocerebellar ataxia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 23, 2017
CompletedFirst Submitted
Initial submission to the registry
October 3, 2024
CompletedFirst Posted
Study publicly available on registry
October 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedFebruary 5, 2026
February 1, 2026
8.5 years
October 3, 2024
February 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
iSARA
Digital measurements collected by wearable inertial sensors during instrumented Scale for the Assessment and Rating of Ataxia (iSARA).
8 Years
Secondary Outcomes (3)
Patient Reported Outcome Measure of Ataxia (PROM-Ataxia)
8 Years
Activities-specific Balance Confidence (ABC) Scale
8 Years
EQ-5D-5L
8 Years
Study Arms (2)
Spinocerebellar Ataxia
Individuals with genetically-confirmed diagnosis of SCA
Healthy Controls
Healthy Controls
Eligibility Criteria
Patients of Ataxia Clinics
You may qualify if:
- Ataxia Group - Individuals who have a genetic-confirmation of SCA diagnosis and are able to sit or stand unassisted for 30 seconds and follow directions.
- Healthy Control Group - Individuals who are able to sit or stand unassisted for 30 seconds and follow directions.
You may not qualify if:
- Any other neurological or musculoskeletal disorder not attributed to the SCA that could affect balance, gait or voluntary movement.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Chicago
Chicago, Illinois, 60637, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2024
First Posted
October 8, 2024
Study Start
June 23, 2017
Primary Completion
December 31, 2025
Study Completion (Estimated)
December 31, 2026
Last Updated
February 5, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share